Page last updated: 2024-09-05

iclaprim and Staphylococcal Skin Infections

iclaprim has been researched along with Staphylococcal Skin Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charrier, C; Hawser, S; Huang, DB; Le Bras, C; Noviello, S	1

Trials

1 trial(s) available for iclaprim and Staphylococcal Skin Infections

Article	Year
The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections. Journal of medical microbiology, 2019, Volume: 68, Issue:6 Topics: Acute Disease; Anti-Bacterial Agents; Double-Blind Method; Humans; Incidence; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin	2019

Article

Year

The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections.

Journal of medical microbiology, 2019, Volume: 68, Issue:6

Topics: Acute Disease; Anti-Bacterial Agents; Double-Blind Method; Humans; Incidence; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin

2019